In the dynamic landscape of pharmaceutical manufacturing, exploiting third-party manufacturers has become a strategic imperative for numerous companies. This trend offers significant perks such as cost reduction and acquisition to specialized expertise. However, achieving optimal efficiency and quality in third-party manufacturing requires a multif